Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

TNXP

Tonix Pharmaceuticals Holding Corp

Sep 18 • 04:00PM ET

0.1451

Dollar change -0.0019
Percentage change -1.29	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-22.15	Insider Own	0.00%	Shs Outstand	127.88M	Perf Week	-3.33%
Market Cap	18.56M	Forward P/E	-	EPS next Y	-10.45	Insider Trans	-	Shs Float	127.87M	Perf Month	-67.39%
Income	-149.01M	PEG	-	EPS next Q	-2.93	Inst Own	0.54%	Short Float	1.23%	Perf Quarter	-88.11%
Sales	12.46M	P/S	1.49	EPS this Y	47.76%	Inst Trans	118.70%	Short Ratio	0.08	Perf Half Y	-98.69%
Book/sh	4.28	P/B	0.03	EPS next Y	27.29%	ROA	-129.55%	Short Interest	1.57M	Perf Year	-99.47%
Cash/sh	0.03	P/C	4.46	EPS next 5Y	-	ROE	-163.24%	52W Range	0.13 - 29.76	Perf YTD	-98.87%
Dividend Est.	-	P/FCF	-	EPS past 5Y	79.31%	ROI	-308.74%	52W High	-99.51%	Beta	2.12
Dividend TTM	-	Quick Ratio	0.72	Sales past 5Y	0.00%	Gross Margin	-17.61%	52W Low	10.51%	ATR (14)	0.05
Dividend Ex-Date	-	Current Ratio	1.15	EPS Y/Y TTM	-61.43%	Oper. Margin	-764.06%	RSI (14)	21.80	Volatility	8.64% 16.97%
Employees	103	Debt/Eq	0.22	Sales Y/Y TTM	-	Profit Margin	-1196.11%	Recom	1.00	Target Price	21.00
Option/Short	No / Yes	LT Debt/Eq	0.15	EPS Q/Q	-619.99%	Payout	-	Rel Volume	0.43	Prev Close	0.15
Sales Surprise	-36.91%	EPS Surprise	-489.01%	Sales Q/Q	-	Earnings	Aug 19 BMO	Avg Volume	20.44M	Price	0.15
SMA20	-37.56%	SMA50	-64.79%	SMA200	-97.72%	Trades		Volume	8,866,308	Change	-1.29%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-18-22	Initiated	Noble Capital Markets	Outperform
Apr-18-19	Upgrade	ROTH Capital	Neutral → Buy	$4
Aug-18-17	Upgrade	ROTH Capital	Neutral → Buy	$6
Sep-07-16	Downgrade	ROTH Capital	Buy → Neutral
Feb-17-16	Reiterated	Oppenheimer	Outperform	$18 → $10
Nov-04-15	Initiated	Cantor Fitzgerald	Buy
Jun-12-15	Initiated	Oppenheimer	Outperform	$18
Feb-17-15	Reiterated	ROTH Capital	Buy	$10 → $12
Sep-29-14	Reiterated	ROTH Capital	Buy	$17 → $10

Sep-18-24 07:30AM	New Hope for Mpox? How TNX-801 Could Meet the WHO's Vaccine Targets for a Safer, Single-Dose Solution (ACCESSWIRE)
Sep-16-24 07:00AM	Tonix Pharmaceuticals Announces That its Single Dose Mpox Vaccine Candidate TNX-801 Aligns with WHO's Newly Issued Preferred Target Product Profile for Mpox Vaccines in Global Health Emergency (GlobeNewswire) -5.93%
Sep-11-24 01:00PM	Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing (ACCESSWIRE)
Sep-10-24 07:00AM	Tonix Pharmaceuticals Announces Appointment of Thomas Englese as Executive Vice President of Commercial Operations (GlobeNewswire) -6.12%
Sep-09-24 07:00AM	Tonix Pharmaceuticals Presented Data on the Potential Mpox Vaccine TNX-801 in Using Synthetic Biology to Battle Mpox Talk at Immunology Symposium at the University of Alberta (GlobeNewswire) +15.86%
07:00AM	Loading…
Sep-06-24 07:00AM	Tonix Pharmaceuticals Launches National Awareness Campaign on the Impact of Gastroparesis or Stomach Paralysis on the Absorption of Oral Migraine Medications at PAINWeek (GlobeNewswire) -10.26%
Sep-04-24 07:00AM	As Research into Pain Accelerates, a Newly Recognized Type of Pain Comes to the Forefront - Tonix Targets it with FDA-Fast Track-Designated TNX-102 SL (ACCESSWIRE)
Aug-29-24 07:00AM	Tonix Pharmaceuticals Presented Data from Two Posters on TNX-102 SL for Reduction of Acute Stress Reaction and Prevention of PTSD and One Poster for Wound Healing at the 2024 Military Health System Research Symposium (MHSRS) (GlobeNewswire) -14.82%
Aug-28-24 07:00AM	Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the 2024 Military Health System Research Symposium (MHSRS) (GlobeNewswire) -17.37%
Aug-26-24 10:41AM	Tonix Pharma Collaborates With World's Largest Vaccine Manufacturer For Mpox Vaccine (Benzinga) +10.00%
07:00AM	Tonix Pharmaceuticals and Bilthoven Biologicals to Collaborate on Advancing Development of Tonix's Mpox Vaccine, TNX-801 (GlobeNewswire)
Aug-23-24 07:45AM	Modern Twist to Centuries-Old Smallpox Vaccine Poised to Combat Deadly Mpox Strain as WHO Declares Global Emergency (ACCESSWIRE)
Aug-21-24 07:00AM	Tonix Pharmaceuticals Announces Oral Presentation and Three Poster Presentations at the 2024 Military Health System Research Symposium (MHSRS) (GlobeNewswire) -5.26%
Aug-20-24 12:34PM	Tonix initiates Phase II trial for emergency cocaine intoxication treatment (Clinical Trials Arena) -14.61%
07:00AM	Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 CATALYST Study of TNX-1300 for the Treatment of Cocaine Intoxication (GlobeNewswire)
06:00AM	Loading…
Aug-19-24 06:00AM	Tonix Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Highlights (GlobeNewswire)
Aug-16-24 10:52PM	TNXP Stock Earnings: Tonix Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 (InvestorPlace)
01:29PM	Tonix Pharmaceuticals' Live Virus Vaccine Candidate Shows Long-Term Protection From Mpox, Smallpox With 1 Dose, Animal Study Suggests (Benzinga)
07:00AM	Tonix Pharmaceuticals Provides Update on the Development of Its Single Dose Live Attenuated Virus Vaccine Candidate for Mpox, TNX-801, as WHO Declares Mpox Outbreak a Global Health Emergency (GlobeNewswire)
Aug-13-24 08:00AM	Tonix Pharmaceuticals to Present at the Summer 2024 Virtual Investor Summit (GlobeNewswire)
Aug-12-24 08:00AM	Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia, the Prototypic Nociplastic Pain Syndrome, at the IASP 2024 World Congress on Pain (GlobeNewswire) +7.00%
Aug-06-24 08:00AM	Tonix Pharmaceuticals Announces Publication in Microorganisms of Technology that Expands Company's Capabilities in Generating Potential Therapeutic Fully Human Antibodies Against SARS-CoV-2 and Other Pathogens (GlobeNewswire)
Aug-01-24 07:45AM	FDA Recognizes Fibromyalgia as a 'Serious Condition' And Fast-Tracks New Drug Candidate (ACCESSWIRE)
Jul-31-24 08:00AM	Tonix Pharmaceuticals Announces Potential Positive Impact of the U.S. National Academies (NASEM) New Definition of Long COVID on the Size of the Fibromyalgia Market for Tonmya (GlobeNewswire) -12.23%
Jul-30-24 08:00AM	Tonix Pharmaceuticals Announces Poster Presentation at the IASP 2024 World Congress on Pain (GlobeNewswire)
Jul-29-24 09:00AM	Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program (PR Newswire)
Jul-25-24 08:30AM	Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected (GlobeNewswire) +9.96%
08:00AM	Tonix Pharmaceuticals Granted Fast Track Designation by FDA for Tonmya for Fibromyalgia (GlobeNewswire)
Jul-24-24 07:45AM	Beyond 'One Bug, One Drug' - Tonix Pharmaceuticals Secures Up To $34 Million In Funding From The U.S. Department Of Defense To Develop a Broad-Spectrum Antiviral (ACCESSWIRE) -7.19%
Jul-22-24 07:00AM	7 Sorry Biotech Stocks Set to Make Investors Sad (InvestorPlace)
12:48PM	Loading…
Jul-19-24 12:48PM	Tonix Pharmaceuticals Awarded potential 34 million dollar Contract with U.S. Department of Defence (News Direct)
Jul-18-24 10:20AM	Tonix Pharmaceuticals receives positive feedback from FDA on Tonmya for fibromyalgia management (News Direct)
Jul-17-24 08:00AM	Tonix Pharmaceuticals, Set to File an NDA for Tonmya for the Management of Fibromyalgia, is Planning Expected Launch in 2H 2025 (ACCESSWIRE)
Jul-10-24 04:30PM	Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering (GlobeNewswire)
Jul-09-24 09:15AM	Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering (GlobeNewswire) -15.47%
07:39AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
Jul-08-24 05:00PM	Tonix Pharmaceuticals Announces Proposed Public Offering (GlobeNewswire) -10.96%
08:00AM	Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmya for the Management of Fibromyalgia (GlobeNewswire)
07:00AM	7 F-Rated Stocks To Sell in July (InvestorPlace)
Jul-01-24 11:07AM	Nano-Cap Tonix Pharmaceuticals Secures Large US Department of Defense Contract (Benzinga)
08:00AM	Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program (GlobeNewswire)
Jun-28-24 04:05PM	Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering (GlobeNewswire)
Jun-27-24 11:01AM	AMZN Stock Alert: Amazon Just Joined the $2 Trillion Club (InvestorPlace) -38.67%
08:37AM	Why Is Tonix Pharmaceuticals (TNXP) Stock Down 33% Today? (InvestorPlace)
08:36AM	Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering (GlobeNewswire)
07:34AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace)
Jun-26-24 04:40PM	Tonix Pharmaceuticals Announces Proposed Public Offering (GlobeNewswire) -10.00%
03:13PM	Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
Jun-25-24 08:00AM	Tonix Pharmaceuticals Presents Vaccine Platform Data in Keynote Talk at the Vaccine Congress 2024 (GlobeNewswire) +5.04%
Jun-21-24 07:30AM	7 F-Rated Penny Stocks to Avoid This June (InvestorPlace)
Jun-20-24 08:00AM	Tonix Pharmaceuticals Announces Positive Pre-NDA CMC Meeting with FDA for Tonmya for the Management of Fibromyalgia (GlobeNewswire) +10.66%
Jun-18-24 12:31PM	Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for June 2024 (InvestorPlace) +8.93%
08:00AM	Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS) (GlobeNewswire)
Jun-17-24 08:00AM	Tonix Pharmaceuticals Presented Poster of Tonmya for the Management of Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2024 (GlobeNewswire)
Jun-13-24 05:00PM	Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering (GlobeNewswire) +5.50%
Jun-12-24 10:06AM	FedEx Layoffs 2024: What to Know About the Latest FDX Job Cuts (InvestorPlace) -47.89%
09:00AM	Tonix Pharmaceuticals Announces Pricing of $4.0 Million Public Offering (GlobeNewswire)
08:52AM	Why Is Tonix Pharmaceuticals (TNXP) Stock Down 40% Today? (InvestorPlace)
07:46AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
Jun-11-24 05:17PM	Tonix Pharmaceuticals Announces Proposed Public Offering (GlobeNewswire)
10:26AM	Tonix Pharmaceuticals Nears Market Entry with Tonmya for Fibromyalgia Management (News Direct)
Jun-10-24 12:14PM	SOUN Stock Alert: SoundHound AI Pays Off Debt Early (InvestorPlace) -33.66%
11:55AM	Why Is Tonix Pharmaceuticals (TNXP) Stock Down 31% Today? (InvestorPlace)
Jun-06-24 11:00AM	Tonix Pharmaceuticals Announces 1-for-32 Reverse Stock Split (GlobeNewswire) -28.04%
08:00AM	Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500 (Fc-modified humanized anti-CD40L mAb) at the American Transplant Congress 2024 (GlobeNewswire)
Jun-05-24 08:00AM	Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2024 (GlobeNewswire)
Jun-03-24 08:00AM	Tonix Pharmaceuticals Presented New Data on Tonmya Suggesting Activity for Improvement in Fibromyalgia-Associated Depression Severity in an Oral Presentation at ASCP Annual Meeting (GlobeNewswire)
May-30-24 08:00AM	Tonix Pharmaceuticals Announces Two Poster Presentations of TNX-102 SL (Sublingual Cyclobenzaprine HCl) at the ASCP Annual Meeting (GlobeNewswire)
May-29-24 08:00AM	Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500 (Fc-modified humanized anti-CD40L mAb) at the American Transplant Congress 2024 (GlobeNewswire)
May-28-24 08:00AM	Tonix Pharmaceuticals Announces Presentation at the 2024 BIO International Convention (GlobeNewswire)
May-22-24 08:00AM	Tonix Pharmaceuticals to Deliver an Oral Presentation and Present Two Posters at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting (GlobeNewswire)
May-21-24 08:00AM	Tonix Pharmaceuticals Announces Key Findings from Initial Phase of EVERSANA Market Opportunity Analysis for Tonmya for the Management of Fibromyalgia (GlobeNewswire)
May-20-24 10:53AM	TNXP Stock Earnings: Tonix Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
May-15-24 08:00AM	Tonix Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase (GlobeNewswire)
May-13-24 04:30PM	Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights (GlobeNewswire) +5.20%
Apr-29-24 09:00AM	Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE) +6.53%
Apr-24-24 08:00AM	Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase (GlobeNewswire)
Apr-09-24 06:31AM	3 Biotech Stocks to Dump Before They Go to Zero (InvestorPlace)
Apr-01-24 04:15PM	Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights (GlobeNewswire)
Mar-28-24 09:32AM	Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering (GlobeNewswire) -43.10%
Mar-25-24 08:00AM	Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome (GlobeNewswire) -5.20%
Mar-24-24 04:05PM	3 Mind-Blowing Stocks That Could Turn $1,000 Into $1 Million (InvestorPlace)
Mar-21-24 08:00AM	Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin Analogues at the American Chemistry Society (ACS) Spring 2024 Meeting (GlobeNewswire)
Mar-20-24 08:00AM	Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch and Commercial Manufacture of Tonmya for the Management of Fibromyalgia (GlobeNewswire)
Mar-19-24 08:00AM	Tonix Pharmaceuticals Announces Transition to Fully Integrated Biopharmaceutical Company Expected on April 1, 2024 (GlobeNewswire)
Mar-12-24 08:00AM	Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring (GlobeNewswire) -8.86%
Mar-11-24 08:00AM	Tonix Pharmaceuticals Reports Improvement in Brain Fog, in Fibromyalgia Patients Treated with Tonmya in RESILIENT, an NDA-Enabling Phase 3 Clinical Trial, at the 6th International Congress on Controversies in Fibromyalgia (GlobeNewswire)
Mar-07-24 09:37AM	New to The Street Announces TV Episode 560 with its Five Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV Tonight, Thursday, March 7, 2024, at 9:30 PM PT (GlobeNewswire)
08:00AM	Tonix Pharmaceuticals Announces Publication in Psychiatry Research Showing Activity of Bedtime TNX-102 SL on PTSD Symptoms and Sleep Quality in Military-Related PTSD at Four Weeks of Therapy (GlobeNewswire)
Mar-06-24 08:00AM	Tonix Pharmaceuticals Selects EVERSANA to Support Launch Strategy and Commercialization Planning of Tonmya for the Management of Fibromyalgia (GlobeNewswire)
Mar-05-24 08:00AM	Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (Fc-modified humanized anti-CD40L mAb) Supports Monthly i.v. Dosing in Humans (GlobeNewswire)
Feb-29-24 08:00AM	Tonix Pharmaceuticals Announces Presentation at The 6th International Congress on Controversies in Fibromyalgia (GlobeNewswire)
Feb-28-24 08:00AM	Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized anti-CD40L mAb) in Healthy Volunteers (GlobeNewswire)
06:56AM	Tonix Pharmaceuticals drug TNX-102 SL gets FDA ok for US Department of Defense funded trial (News Direct)
06:54AM	Tonix Pharmaceuticals' Fibromyalgia Trial Shows Promising Results in Webinar Presentation (News Direct)
Feb-27-24 08:00AM	Tonix Pharmaceuticals Announces Positive Results from Clinical Pharmacokinetic Bridging Study of Tonmya to Support Development and Partnering in Japan and China (GlobeNewswire) +6.88%
Feb-26-24 08:00AM	New Drug Study Shows Improving Sleep Quality Can Relieve Fibromyalgia Pain (ACCESSWIRE) +6.93%
Feb-25-24 02:12PM	3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond (InvestorPlace)
Feb-23-24 09:30AM	New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised Series (GlobeNewswire)
Feb-20-24 08:00AM	Tonix Pharmaceuticals to Participate in the 2024 BIO CEO & Investor Conference (GlobeNewswire)

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TNXP

Tonix Pharmaceuticals Holding Corp

Upgrade your FINVIZ experience